Published Papers & Misc - TANAKA Hajime

Division display >> ／  All the affair displays  1 - 189 of about 189

  1. Wei Chen, Soichiro Yoshida, Noriyoshi Miura, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Yasuhisa Fujii. Efficacy of docetaxel addition to next-generation androgen receptor-axis-targeted therapies and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: A tumor volume-specific analysis. Int J Urol. 2024.12; ( PubMed, DOI )

  2. Cesare Saitta, Giuseppe Garofano, Jonathan A Afari, Hajime Tanaka, Dattatraya Patil, Kit L Yuen, Luke Wang, Julian Cortes, Margaret F Meagher, Dhruv Puri, Clara Cerrato, Mimi V Nguyen, Kevin Hakimi, Masaki Kobayashi, Shohei Fukuda, Marco Paciotti, Massimo Lazzeri, Giovanni Lughezzani, Nicolò M Buffi, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh. NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2024.12; 22 (6): 102232. ( PubMed, DOI )

  3. Yuki Nakamura, Soichiro Yoshida, Yuki Arita, Ryo Takeshita, Koichiro Kimura, Masaki Kobayashi, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Masahiro Jinzaki, Yasuhisa Fujii. The need for a second transurethral resection in high-risk non-muscle-invasive bladder cancer based on the Vesicle Imaging-Reporting and Data System. Int J Urol. 2024.12; ( PubMed, DOI )

  4. Soichiro Yoshida, Yuya Maezawa, Kensaku Ishihara, Naoki Inoue, Kenji Tanabe, Keita Izumi, Motohiro Fujiwara, Masahiro Toide, Takanobu Yamamoto, Sho Uehara, Saori Araki, Masaharu Inoue, Ryoji Takazawa, Noboru Numao, Yukihiro Ohtsuka, Hajime Tanaka, Yasuhisa Fujii. Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastases. Int J Urol. 2024.11; 31 (11): 1234-1240. ( PubMed, DOI )

  5. Yuki Nakamura, Yudai Ishikawa, Masaki Kobayashi, Motohiro Fujiwara, Bo Fan, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Location-specific diagnostic efficiency of photodynamic diagnosis-guided biopsy in bladder mapping biopsies. Int J Urol. 2024.11; 31 (11): 1263-1268. ( PubMed, DOI )

  6. Hajime Tanaka, Yuki Fukawa, Kouhei Yamamoto, Kousuke Tanimoto, Akira Takemoto, Takayasu Mori, Hisashi Hasumi, Mayumi Kinoshita, Takumi Kanazawa, Asuka Furukawa, Koichiro Kimura, Hiroyuki Sato, Akihiro Hirakawa, Shohei Fukuda, Yuma Waseda, Soichiro Yoshida, Steven C Campbell, Yasuhisa Fujii. Prognostic Impact and Genomic Backgrounds of Renal Parenchymal Infiltration or Micronodular Spread in Nonmetastatic Clear Cell Renal Cell Carcinoma. Mod Pathol. 2024.11; 37 (11): 100590. ( PubMed, DOI )

  7. Tomoki Yanagi, Hiroaki Kikuchi, Koh Takeuchi, Koichiro Susa, Takayasu Mori, Motoko Chiga, Kouhei Yamamoto, Asuka Furukawa, Takumi Kanazawa, Yuki Kato, Naohiro Takahashi, Takefumi Suzuki, Yutaro Mori, Benjamin C Carter, Makiko Mori, Yuta Nakano, Tamami Fujiki, Yu Hara, Soichiro Suzuki, Fumiaki Ando, Shintaro Mandai, Shinya Honda, Satoru Torii, Shigeomi Shimizu, Hajime Tanaka, Yasuhisa Fujii, Tatemitsu Rai, Shinichi Uchida, Eisei Sohara. ULK1-regulated AMP sensing by AMPK and its application for the treatment of chronic kidney disease. Kidney Int. 2024.11; 106 (5): 887-906. ( PubMed, DOI )

  8. Yuya Maezawa, Masaki Kobayashi, Masanori Murakami, Ayumi Yamamura, Shotaro Naito, Hajime Tanaka, Soichiro Yoshida, Tetsuya Yamada, Yasuhisa Fujii. Prolonged hypoglycemia after the resection of pheochromocytoma in a hemodialysis patient. IJU Case Rep. 2024.11; 7 (6): 431-433. ( PubMed, DOI )

  9. Julian A Cortes, Cesare Saitta, Kit L Yuen, Dattatraya Patil, Hajime Tanaka, Dhruv Puri, Jonathan A Afari, Mirha Mahmood, Joshua Matian, Mariam Mansour, Aaron Ahdoot, Luke Wang, Margaret F Meagher, Melis Guer, Mai Dabbas, Mimi V Nguyen, Clara Cerrato, Masaki Kobayashi, Shohei Fukuda, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh. Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) Registry. Clin Genitourin Cancer. 2024.10; 22 (5): 102126. ( PubMed, DOI )

  10. Franklin Liu, Luke Wang, Margaret F Meagher, Jonathan Afari, Cesare Saitta, Sohail Dhanji, Saeed Ghassemzadeh, Aastha Shah, Dhruv Puri, Mimi V Nguyen, Kevin Hakimi, Benjamin Schmeusser, Rachel Greenwald, Alexandra Medline, Fatima Kamal, Adil Ali, Shohei Fukuda, Masaki Kobayashi, Wei Chen, Bo Fan, Yusuke Aida, Yuya Maezawa, Shintaro Asai, Hajime Tanaka, Dattatraya Patil, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh. Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) database. Urol Oncol. 2024.10; 42 (10): 333.e21-333.e31. ( PubMed, DOI )

  11. Hiroki Tanaka, Soichiro Yoshida, Satoru Aoyama, Sadakatsu Ikeda, Junko Kunieda, Kenichi Ohashi, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Yasuhisa Fujii. mutation and high tumor mutation burden treated sequentially with olaparib and pembrolizumab. IJU Case Rep. 2024.09; 7 (5): 395-398. ( PubMed, DOI )

  12. Kenji Tanabe, Shuichiro Kobayashi, Yuya Maezawa, Kensaku Ishihara, Naoki Inoue, Keita Izumi, Motohiro Fujiwara, Masahiro Toide, Takanobu Yamamoto, Sho Uehara, Saori Araki, Masaharu Inoue, Ryoji Takazawa, Noboru Numao, Yukihiro Ohtsuka, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study. Int J Clin Oncol. 2024.09; 29 (9): 1302-1310. ( PubMed, DOI )

  13. Motohiro Fujiwara, Wataru Shimada, Minato Yokoyama, Anri Koyanagi, Hiroshi Shintaku, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma. IJU Case Rep. 2024.07; 7 (4): 293-296. ( PubMed, DOI )

  14. Masaki Kobayashi, Yoh Matsuoka, Sho Uehara, Hiroshi Tanaka, Motohiro Fujiwara, Yuki Nakamura, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Utility of positive core number on MRI-ultrasound fusion targeted biopsy in combination with PI-RADS scores for predicting unexpected extracapsular extension of clinically localized prostate cancer. Int J Urol. 2024.07; 31 (7): 739-746. ( PubMed, DOI )

  15. Masahiro Toide, Hajime Tanaka, Masaki Kobayashi, Motohiro Fujiwara, Yuki Nakamura, Shohei Fukuda, Koichiro Kimura, Yuma Waseda, Soichiro Yoshida, Ukihide Tateishi, Yasuhisa Fujii. Stepwise algorithm using computed tomography and magnetic resonance imaging for differential diagnosis of fat-poor angiomyolipoma in small renal masses: A prospective validation study. Int J Urol. 2024.07; 31 (7): 778-784. ( PubMed, DOI )

  16. Cesare Saitta, Jonathan A Afari, Dattatraya Patil, Hajime Tanaka, Kit L Yuen, Luke Wang, Julian Cortes, Franklin Liu, Mirha Mahmood, Joshua Matian, Mariam Mansour, Dhruv Puri, Clara Cerrato, Mimi V Nguyen, Kevin Hakimi, Masaki Kobayashi, Shohei Fukuda, Margaret F Meagher, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh. Association of Elevated C-Reactive Protein with Worsened Outcomes in Different Histologies of Renal Cortical Tumors: Analysis of the INMARC Registry. Clin Genitourin Cancer. 2024.06; 22 (3): 102098. ( PubMed, DOI )

  17. Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Shuya Kandori, Kazutoshi Fujita, Kosuke Ueda, Hajime Tanaka, Ryotaro Tomida, Toshifumi Kurahashi, Yukari Bando, Naotaka Nishiyama, Takahiro Kimura, Shimpei Yamashita, Hiroshi Kitamura, Hideaki Miyake, . Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy. Int J Urol. 2024.05; 31 (5): 526-533. ( PubMed, DOI )

  18. Cesare Saitta, Jonathan A Afari, Arman Walia, Dattatraya Patil, Hajime Tanaka, Kevin Hakimi, Luke Wang, Margaret F Meagher, Franklin Liu, Mimi V Nguyen, Dhruv Puri, Clara Cerrato, Ava Saidian, Masaki Kobayashi, Shohei Fukuda, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh. Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registry. Urol Oncol. 2024.04; 42 (4): 119.e1-119.e16. ( PubMed, DOI )

  19. Madoka Kataoka, Minato Yokoyama, Yuma Waseda, Masaya Ito, Masaki Kobayashi, Motohiro Fujiwara, Yuki Nakamura, Yudai Ishikawa, Shohei Fukuda, Hajime Tanaka, Soichiro Yoshida, Hitoshi Masuda, Yasuhisa Fujii. Longitudinal deterioration in lower urinary tract symptoms after artificial urinary sphincter implantation in patients with a history of pelvic radiation therapy. Low Urin Tract Symptoms. 2024.01; 16 (1): e12507.

  20. Matsuoka Y, Ueno Y, Uehara S, Tanaka H, Kobayashi M, Tanaka H, Yoshida S, Yokoyama M, Kumazawa I, Fujii Y. Deep-learning prostate cancer detection and segmentation on biparametric versus multiparametric magnetic resonance imaging: Added value of dynamic contrast-enhanced imaging. International journal of urology : official journal of the Japanese Urological Association. 2023.12; 30 (12): 1103-1111. ( PubMed, DOI )

  21. Chen W, Yokoyama M, Waseda Y, Kobayashi M, Fan B, Fukuda S, Tanaka H, Yoshida S, Ai M, Fushimi K, Fujii Y. Surgical outcomes of robot-assisted radical cystectomy in octogenarian or older patients: A Japanese nationwide study. International journal of urology : official journal of the Japanese Urological Association. 2023.11; 30 (11): 1014-1019. ( PubMed, DOI )

  22. Kataoka M, Yokoyama M, Waseda Y, Ito M, Kobayashi M, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Tanaka H, Yoshida S, Masuda H, Fujii Y. Longitudinal deterioration in lower urinary tract symptoms after artificial urinary sphincter implantation in patients with a history of pelvic radiation therapy. Lower urinary tract symptoms. 2023.11; ( PubMed, DOI )

  23. Ishikawa Y, Tanaka H, Fujiwara M, Nakamura Y, Fukuda S, Waseda Y, Yoshida S, Yokoyama M, Fujii Y. Incidence and predictors of intraoperative hypotension during transurethral bladder tumor resection with oral 5-aminolevulinic acid. International journal of urology : official journal of the Japanese Urological Association. 2023.11; ( PubMed, DOI )

  24. Ohba K, Monji K, Osawa T, Yamana K, Yasuda Y, Tanaka H, Nakagawa Y, Fukuyama T, Matsubara N, Uemura H, Sakai H, Eto M. Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study. International journal of urology : official journal of the Japanese Urological Association. 2023.11; 30 (11): 977-984. ( PubMed, DOI )

  25. Ohba Kojiro, Monji Keisuke, Osawa Takahiro, Yamana Kazutoshi, Yasuda Yosuke, Tanaka Hajime, Nakagawa Yuki, Fukuyama Tamaki, Matsubara Nobuaki, Uemura Hirotsugu, Sakai Hideki, Eto Masatoshi. Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study(タイトル和訳中) International Journal of Urology. 2023.11; 30 (11): 977-984. ( ichushi )

  26. Chen Wei, Yokoyama Minato, Waseda Yuma, Kobayashi Masaki, Fan Bo, Fukuda Shohei, Tanaka Hajime, Yoshida Soichiro, Ai Masumi, Fushimi Kiyohide, Fujii Yasuhisa. Surgical outcomes of robot-assisted radical cystectomy in octogenarian or older patients: A Japanese nationwide study(タイトル和訳中) International Journal of Urology. 2023.11; 30 (11): 1014-1019. ( ichushi )

  27. Kaneko Hiroki, Fujiwara Motohiro, Tanaka Hajime, Kimura Koichiro, Yoshida Soichiro, Fujii Yasuhisa. Texture feature analysis using dynamic computed tomography for preoperative risk stratification in upper urinary tract urothelial carcinoma(タイトル和訳中) International Journal of Urology. 2023.11; 30 (11): 1056-1058. ( ichushi )

  28. Sazuka T, Matsushita Y, Sato H, Osawa T, Hinata N, Hatakeyama S, Numakura K, Ueda K, Kimura T, Takahashi M, Tanaka H, Kawasaki Y, Kurahashi T, Kato T, Fujita K, Miyake M, Kojima T, Kitamura H, Miyake H, Ichikawa T. Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study. Scientific reports. 2023.11; 13 (1): 20629. ( PubMed, DOI )

  29. Fujiwara M, Tanaka H, Kobayashi M, Nakamura Y, Fan B, Ishikawa Y, Fukuda S, Toda K, Yoshida S, Yokoyama M, Yoshimura R, Fujii Y. Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients. Clinical genitourinary cancer. 2023.11; ( PubMed, DOI )

  30. Kaneko H, Fujiwara M, Tanaka H, Kimura K, Yoshida S, Fujii Y. Texture feature analysis using dynamic computed tomography for preoperative risk stratification in upper urinary tract urothelial carcinoma. International journal of urology : official journal of the Japanese Urological Association. 2023.11; 30 (11): 1056-1058. ( PubMed, DOI )

  31. Yamaguchi Y, Tanaka H, Kimura K, Fukuda S, Fukushima H, Waseda Y, Yoshida S, Yokoyama M, Hirakawa A, Tateishi U, Campbell SC, Fujii Y. Prognostic impact of the radiological infiltrative feature of primary renal tumor in metastatic renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association. 2023.10; 30 (10): 913-921. ( PubMed, DOI )

  32. Yamaguchi Yoshitomo, Tanaka Hajime, Kimura Koichiro, Fukuda Shohei, Fukushima Hiroshi, Waseda Yuma, Yoshida Soichiro, Yokoyama Minato, Hirakawa Akihiro, Tateishi Ukihide, Campbell Steven C., Fujii Yasuhisa. Prognostic impact of the radiological infiltrative feature of primary renal tumor in metastatic renal cell carcinoma(タイトル和訳中) International Journal of Urology. 2023.10; 30 (10): 913-921. ( ichushi )

  33. Fan B, Yokoyama M, Kobayashi M, Nakamura Y, Fujiwara M, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y. Incidence, risk factors, and significance of 20% decrease from new baseline estimated glomerular filtration rate after radical and partial nephrectomy within 2 years. International journal of urology : official journal of the Japanese Urological Association. 2023.10; ( PubMed, DOI )

  34. Kimura K, Yoshida S, Tsuchiya J, Kitazume Y, Waseda Y, Tanaka H, Yokoyama M, Toda K, Yoshimura R, Masaya I, Koga F, Tateishi U, Fujii Y. Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer. European radiology. 2023.09; 33 (9): 6245-6255. ( PubMed, DOI )

  35. Yoshida Soichiro, Takahara Taro, Tanaka Hajime, Yokoyama Minato, Yoshimura Ryoichi, Fujii Yasuhisa. The role of prostate-specific antigen changes in predicting overall survival after progressive-site directed therapy for oligoprogressive castration-resistant prostate cancer(タイトル和訳中) International Journal of Urology. 2023.07; 30 (7): 616-617. ( ichushi )

  36. Soma Takahiko, Yoshida Soichiro, Wakejima Ryo, Taguchi Towako, Fukuda Shohei, Tanaka Hajime, Yokoyama Minato, Ohashi Kenichi, Okubo Kenichi, Fujii Yasuhisa. A case of repeat oligoprogressive castration-resistant prostate cancer treated with pulmonary metastasectomy IJU Case Reports. 2023.07; 6 (4): 216-218. ( ichushi )

  37. Yoshida S, Takahara T, Tanaka H, Yokoyama M, Yoshimura R, Fujii Y. The role of prostate-specific antigen changes in predicting overall survival after progressive-site directed therapy for oligoprogressive castration-resistant prostate cancer. International journal of urology : official journal of the Japanese Urological Association. 2023.07; 30 (7): 616-617. ( PubMed, DOI )

  38. Soma T, Yoshida S, Wakejima R, Taguchi T, Fukuda S, Tanaka H, Yokoyama M, Ohashi K, Okubo K, Fujii Y. A case of repeat oligoprogressive castration-resistant prostate cancer treated with pulmonary metastasectomy. IJU case reports. 2023.07; 6 (4): 216-218. ( PubMed, DOI )

  39. Soma T, Fukuda S, Matsuyama Y, Ikeda R, Inoue M, Waseda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujiwara T, Kageyama Y, Fujii Y. Peritoneal closure and the processus vaginalis transection method to prevent inguinal hernia after robot-assisted radical prostatectomy. International journal of urology : official journal of the Japanese Urological Association. 2023.06; 30 (6): 532-538. ( PubMed, DOI )

  40. Soma Takahiko, Fukuda Shohei, Matsuyama Yusuke, Ikeda Riko, Inoue Masaharu, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Fujiwara Takeo, Kageyama Yukio, Fujii Yasuhisa. ロボット支援前立腺全摘除術後の鼠径ヘルニア予防のための腹膜閉鎖および鞘状突起離断法(Peritoneal closure and the processus vaginalis transection method to prevent inguinal hernia after robot-assisted radical prostatectomy) International Journal of Urology. 2023.06; 30 (6): 532-538. ( ichushi )

  41. Uchida Y, Yokoyama M, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujiwara T, Fujii Y. Preservation of Erectile and Ejaculatory Functions After Tetramodal Bladder-Sparing Therapy Incorporating Consolidative Partial Cystectomy Against Muscle Invasive Bladder Cancer. Urology research & practice. 2023.05; 49 (3): 162-168. ( PubMed, DOI )

  42. Nakamura Yuki, Fukushima Hiroshi, Yoshitomi Kasumi, Soma Takahiko, Kobayashi Masaki, Fan Bo, Fujiwara Motohiro, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Fujii Yasuhisa. 筋層非浸潤性膀胱癌の増悪予測における背側膀胱頸部浸潤の重要性(Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer) International Journal of Urology. 2023.04; 30 (4): 381-388. ( ichushi )

  43. Fujiwara M, Yoshida S, Takahara T, Soma T, Nakamura Y, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yokoyama M, Fujii Y. Prostate and metastasis diffusion volume based on apparent diffusion coefficient as a prognostic factor in Hormone-naïve prostate Cancer. Clinical & experimental metastasis. 2023.04; 40 (2): 187-195. ( PubMed, DOI )

  44. Chen W, Yokoyama M, Kobayashi M, Fan B, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Ai M, Fushimi K, Nonomura N, Fujii Y. Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study. International journal of urology : official journal of the Japanese Urological Association. 2023.03; 30 (3): 258-263. ( PubMed, DOI )

  45. Fujiwara Motohiro, Yokoyama Minato, Toide Masahiro, Fujiwara Ryo, Tanaka Hajime, Oguchi Tomohiko, Komai Yoshinobu, Yoshida Soichiro, Matsuoka Yoh, Numao Noboru, Yamamoto Shinya, Fukui Iwao, Yonese Junji, Fujii Yasuhisa. 筋層浸潤性膀胱癌患者に対する最大限の経尿道的切除術、導入化学放射線療法、地固め部分膀胱切除術からなる選択的4者併用膀胱温存療法後の腎機能転帰と根治的膀胱全摘術後の腎機能転帰との比較　2施設後ろ向き研究(Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study) Japanese Journal of Clinical Oncology. 2023.03; 53 (3): 263-269. ( ichushi )

  46. Chen Wei, Yokoyama Minato, Kobayashi Masaki, Fan Bo, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Ai Masumi, Fushimi Kiyohide, Nonomura Norio, Fujii Yasuhisa. 根治的膀胱摘除術の動向およびロボット支援根治的膀胱摘除術に注目した外科的アプローチ間の手術成績の比較　日本の全国データベース研究(Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study) International Journal of Urology. 2023.03; 30 (3): 258-263. ( ichushi )

  47. Fujiwara M, Yokoyama M, Toide M, Fujiwara R, Tanaka H, Oguchi T, Komai Y, Yoshida S, Matsuoka Y, Numao N, Yamamoto S, Fukui I, Yonese J, Fujii Y. Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study. Japanese journal of clinical oncology. 2023.03; 53 (3): 263-269. ( PubMed, DOI )

  48. Yoshida, S; Takahara, T; Arita, Y; Ito, M; Hayakawa, S; Oguchi, T; Komai, Y; Numao, N; Yuasa, T; Inoue, M; Ushijima, H; Kudo, S; Shimano, Y; Nakamura, Y; Uchida, Y; Uehara, S; Tanaka, H; Yaegashi, H; Izumi, K; Yokoyama, M; Matsuoka, Y; Yoshioka, Y; Konishi, K; Nakanishi, K; Nagahara, A; Hirakawa, A; Koike, R; Koga, F; Nishimura, K; Mizokami, A; Yonese, J; Kageyama, Y; Yoshimura, R; Fujii, Y. A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL) BMC UROLOGY. 2023.03; 23 (1): 33. ( PubMed, DOI )

  49. Hajime Tanaka, Shohei Fukuda, Koichiro Kimura, Yuki Fukawa, Kouhei Yamamoto, Hiroshi Fukushima, Shingo Moriyama, Yosuke Yasuda, Sho Uehara, Yuma Waseda, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Kazutaka Saito, Ukihide Tateishi, Steven C Campbell, Yasuhisa Fujii. Defining Tumour Shape Irregularity for Preoperative Risk Stratification of Clinically Localised Renal Cell Carcinoma. Eur Urol Open Sci. 2023.02; 48 36-43. ( PubMed, DOI )

  50. Nguyen MV, Walia A, Saidian A, Puri D, Meagher MF, Hakimi K, Tanaka H, Patil D, Yasuda Y, Saito K, Dhanji S, Cerrato C, Narasimhan R, Perry J, Master V, Fujii Y, Derweesh IH. Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma. BJU international. 2023.02; 131 (2): 219-226. ( PubMed, DOI )

  51. Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Fujiwara M, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Patterns of recurrence in genuine and induced oligometastatic castration-resistant prostate cancer treated with progressive site-directed therapy. International journal of urology : official journal of the Japanese Urological Association. 2023.02; 30 (2): 204-210. ( PubMed, DOI )

  52. Yoshida Soichiro, Takahara Taro, Arita Yuki, Toda Kazuma, Kimura Koichiro, Fujiwara Motohiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa. Progressive site-directed therapyを施行したgenuineおよびinduced oligometastasisを伴う去勢抵抗性前立腺癌の再発パターン(Patterns of recurrence in genuine and induced oligometastatic castration-resistant prostate cancer treated with progressive sitedirected therapy) International Journal of Urology. 2023.02; 30 (2): 204-210. ( ichushi )

  53. Yuki Nakamura, Hiroshi Fukushima, Kasumi Yoshitomi, Takahiko Soma, Masaki Kobayashi, Bo Fan, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yasuhisa Fujii. Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer. Int J Urol. 2022.12; 30 (4): 381-388. ( PubMed, DOI )

  54. Chen W, Yokoyama M, Kobayashi M, Fan B, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Ai M, Fushimi K, Nonomura N, Fujii Y. Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study Int J Urol. 2022.12;

  55. Julia H Yuan, Hajime Tanaka, Dattatraya Patil, Kevin Hakimi, Shady Soliman, Margaret F Meagher, Ava Saidian, Arman Walia, Sohail Dhanji, Franklin Liu, Jonathan Afari, Mimi Nguyen, Luke Wang, Yosuke Yasuda, Kazutaka Saito, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh. Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFR. Clin Genitourin Cancer. 2022.12; 21 (4): e219-e227. ( PubMed, DOI )

  56. Keiner C, Meagher M, Patil D, Saito K, Walia A, Liu F, Dutt R, Miller N, Dhanji S, Saidian A, Wan F, Yasuda Y, Fujii Y, Tanaka H, Master V, Derweesh I.. Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: A multicenter analysis Front Oncol. 2022.11; ( DOI )

  57. Yamaguchi Y, Yokoyama M, Takemoto A, Nakamura Y, Fukuda S, Uehara S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma. IJU case reports. 2022.11; 5 (6): 480-483. ( PubMed, DOI )

  58. Yamaguchi Yoshitomo, Yokoyama Minato, Takemoto Akira, Nakamura Yuki, Fukuda Shohei, Uehara Sho, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Fujii Yasuhisa. コハク酸脱水素酵素欠損性腎細胞癌を合併したコハク酸脱水素酵素欠損性の悪性パラガングリオーマ(Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma) IJU Case Reports. 2022.11; 5 (6): 480-483. ( ichushi )

  59. Shimada Wataru, Kimura Koichiro, Tanaka Hajime, Fukuda Shohei, Yoshida Soichiro, Fujii Yasuhisa. 不規則な腫瘍形の重要性　cT1b-2N0M0腎細胞癌のpT3aへのステージ上昇を予測するためのダイナミックCTに基づくラジオミクス解析(Significance of tumor shape irregularity: Radiomics analysis based on dynamic computed tomography for predicting pT3a upstaging in cT1b-2N0M0 renal cell carcinoma) International Journal of Urology. 2022.11; 29 (11): 1387-1389. ( ichushi )

  60. Tanaka H, Fujii Y. Editorial Comment to Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma Int J Urol. 2022.08; 29 (8): 822-823.

  61. Yamamoto S, Fukushima H, Fukuda S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab Asia Pac J Clin Oncol (IF: 2.6; Q4). 2022.08;

  62. Toide M, Saito K, Yasuda Y, Tanaka H, Fukuda S, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y.. Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort. Clin Genitourin Cancer. . 2022.08;

  63. Yamamoto S, Fukushima H, Fukuda S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab. Asia-Pacific journal of clinical oncology. 2022.08; 18 (4): 410-418. ( PubMed, DOI )

  64. Toide M, Saito K, Yasuda Y, Tanaka H, Fukuda S, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y. Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort. Clinical genitourinary cancer. 2022.08; 20 (4): e276-e282. ( PubMed, DOI )

  65. Tanaka Hajime, Fujii Yasuhisa. 「進行性腎細胞癌の一次治療としての複合癌免疫療法の包括的評価」に対するエディトリアルコメント(Editorial Comment to Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma) International Journal of Urology. 2022.08; 29 (8): 822-823. ( ichushi )

  66. Tanaka H, Fujii Y. Editorial Comment to Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association. 2022.08; 29 (8): 822-823. ( PubMed, DOI )

  67. Tanaka H, Fujii Y. Editorial Comment to Surgical and focal treatment for metastatic renal cell carcinoma: A literature review. Int J Urol. 2022.06; 29 (6): 501-502.

  68. Matsumoto S, Arita Y, Yoshida S, Fukushima H, Kimura K, Yamada I, Tanaka H, Yagi F, Yokoyama M, Matsuoka Y, Oya M, Tateishi U, Jinzaki M, Fujii Y. Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation Abdom Radiol (NY) (IF: 3.04; Q2). 2022.06;

  69. Tanaka H, Fujii Y. Editorial Comment to Surgical and focal treatment for metastatic renal cell carcinoma: A literature review. International journal of urology : official journal of the Japanese Urological Association. 2022.06; 29 (6): 501-502. ( PubMed, DOI )

  70. Tanaka Hajime, Fujii Yasuhisa. 「転移性腎細胞癌に対する外科的局所治療　文献レビュー」に対するエディトリアルコメント(Editorial Comment to Surgical and focal treatment for metastatic renal cell carcinoma: A literature review) International Journal of Urology. 2022.06; 29 (6): 501-502. ( ichushi )

  71. Matsumoto S, Arita Y, Yoshida S, Fukushima H, Kimura K, Yamada I, Tanaka H, Yagi F, Yokoyama M, Matsuoka Y, Oya M, Tateishi U, Jinzaki M, Fujii Y. Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation. Abdominal radiology (New York). 2022.06; 47 (6): 2178-2186. ( PubMed, DOI )

  72. Nityam Rathi, Diego A Palacios, Emily Abramczyk, Hajime Tanaka, Yunlin Ye, Jianbo Li, Yosuke Yasuda, Robert Abouassaly, Mohamed Eltemamy, Alvin Wee, Christopher Weight, Steven C Campbell. Predicting GFR after radical nephrectomy: the importance of split renal function. World J Urol. 2022.04; 40 (4): 1011-1018. ( PubMed, DOI )

  73. Matsuoka Y, Uehara S, Toda K, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Yoshimura R, Kihara K, Fujii Y. Focal brachytherapy for localized prostate cancer: 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy Urol Oncol (IF: 3.5; Q3). 2022.04;

  74. Matsuoka Y, Uehara S, Toda K, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Yoshimura R, Kihara K, Fujii Y. Focal brachytherapy for localized prostate cancer: 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy. Urologic oncology. 2022.04; 40 (4): 161.e15-161.e23. ( PubMed, DOI )

  75. Uchida Y, Yoshida S, Arita Y, Shimoda H, Kimura K, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Jinzaki M, Fujii Y. Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma Diagnostics (Basel) (IF: 5.25; Q2). 2022.03;

  76. Uchida Y, Yoshida S, Arita Y, Shimoda H, Kimura K, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Jinzaki M, Fujii Y. Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma. Diagnostics (Basel, Switzerland). 2022.03; 12 (4): ( PubMed, DOI )

  77. Nguyen MV, Walia A, Saidian A, Puri D, Meagher MF, Hakimi K, Tanaka H, Patil D, Yasuda Y, Saito K, Dhanji S, Cerrato C, Narasimhan R, Perry J, Master V, Fujii Y, Derweesh IH. Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma BJU Int. 2022.02; 131 (2): 219-226.

  78. Kimura K, Yoshida S, Tsuchiya J, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Tateishi U, Fujii Y. Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer Eur Radiol (IF: 5.32; Q1). 2022.02;

  79. Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response 2022.01;

  80. Kimura K, Yoshida S, Tsuchiya J, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Tateishi U, Fujii Y. Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer. European radiology. 2022.01; 32 (1): 671-679. ( PubMed, DOI )

  81. Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response. Cancers. 2022.01; 14 (3): ( PubMed, DOI )

  82. Preedanan W, Suzuki K, Kondo T, Kobayashi M, Tanaka H, Ishioka J, Matsuoka Y, Fujii Y, Kumazawa I. Improvement of Urinary Stone Segmentation Using GAN-Based Urinary Stones Inpainting Augmentation. IEEE Access. 2022;

  83. Fujiwara M, Yokoyama M, Toide M, Fujiwara R, Tanaka H, Oguchi T, Komai Y, Yoshida S, Matsuoka Y, Numao N, Yamamoto S, Fukui I, Yonese J, Fujii Y. Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study Jpn J Clin Oncol. 2022;

  84. Rossi SH, Tanaka H, Usher-Smith JA, Bernhard JC, Fujii Y, Stewart GD . Kidney Cancer Screening and Epidemiology. Société Internationale d’Urologie Journal. 2022;

  85. Keiner C, Meagher M, Patil D, Saito K, Walia A, Liu F, Dutt R, Miller N, Dhanji S, Saidian A, Wan F, Yasuda Y, Fujii Y, Tanaka H, Master V, Derweesh I. Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: A multicenter analysis. Frontiers in oncology. 2022; 12 995991. ( PubMed, DOI )

  86. Ishikawa Y, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Sakai Y, Otsuka Y, Takazawa R, Yano M, Tsukamoto T, Okuno T, Noro A, Nagahama K, Kamata S, Fujii Y. Prognostic Accuracy of the qSOFA Score for In-Hospital Mortality in Elderly Patients with Obstructive Acute Pyelonephritis: A Multi-Institutional Study Diagnostics (Basel). 2021.12;

  87. Yokoyama Minato, Ishioka Junichiro, Toba Mikayo, Fukushima Hiroshi, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Ai Masumi, Fushimi Kiyohide, Fujii Yasuhisa. 日本におけるロボット支援腎部分切除術の政府承認後2年間の動向と安全性　2016年から2018年までの全国データベース研究(Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018) International Journal of Urology. 2021.12; 28 (12): 1268-1272. ( ichushi )

  88. Shimada Wataru, Tanaka Hajime, Fukawa Yuki, Kimura Koichiro, Yamamoto Kouhei, Fukuda Shohei, Fukushima Hiroshi, Yasuda Yosuke, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Tateishi Ukihide, Campbell Steven C., Fujii Yasuhisa. 局所進行腎細胞癌における浸潤性腫瘍の正常腎実質との界面　臨床的意義と病理学的意味(Infiltrative tumor interface with normal renal parenchyma in locally advanced renal cell carcinoma: Clinical relevance and pathological implications) International Journal of Urology. 2021.12; 28 (12): 1233-1239. ( ichushi )

  89. Shimada W, Tanaka H, Fukawa Y, Kimura K, Yamamoto K, Fukuda S, Fukushima H, Yasuda Y, Uehara S, Yoshida S, Yokoyama M, Matsuoka Y, Tateishi U, Campbell SC, Fujii Y. Infiltrative tumor interface with normal renal parenchyma in locally advanced renal cell carcinoma: Clinical relevance and pathological implications. International journal of urology : official journal of the Japanese Urological Association. 2021.12; 28 (12): 1233-1239. ( PubMed, DOI )

  90. Ishikawa Y, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Sakai Y, Otsuka Y, Takazawa R, Yano M, Tsukamoto T, Okuno T, Noro A, Nagahama K, Kamata S, Fujii Y. Prognostic Accuracy of the qSOFA Score for In-Hospital Mortality in Elderly Patients with Obstructive Acute Pyelonephritis: A Multi-Institutional Study. Diagnostics (Basel, Switzerland). 2021.12; 11 (12): ( PubMed, DOI )

  91. Yokoyama M, Ishioka J, Toba M, Fukushima H, Tanaka H, Yoshida S, Matsuoka Y, Ai M, Fushimi K, Fujii Y. Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018. International journal of urology : official journal of the Japanese Urological Association. 2021.12; 28 (12): 1268-1272. ( PubMed, DOI )

  92. Maruyama Riko, Fukushima Hiroshi, Fukuda Shohei, Yasuda Yosuke, Uehara Sho, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 副腎腫瘍および腎腫瘍の清潔手術における予防的抗菌薬の不使用　連続患者1362例を対象としたリスクベース戦略の結果(Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk-based strategy in 1362 consecutive patients) International Journal of Urology. 2021.10; 28 (10): 1032-1038. ( ichushi )

  93. Maruyama R, Fukushima H, Fukuda S, Yasuda Y, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Fujii Y. Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk-based strategy in 1362 consecutive patients. International journal of urology : official journal of the Japanese Urological Association. 2021.10; 28 (10): 1032-1038. ( PubMed, DOI )

  94. Motohiro Fujiwara, Hajime Tanaka, Takeshi Yuasa, Yoshinobu Komai, Tomohiko Oguchi, Ryo Fujiwara, Noboru Numao, Shinya Yamamoto, Yasuhisa Fujii, Iwao Fukui, Junji Yonese. First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice. Int J Urol. 2021.09; 28 (9): 920-926. ( PubMed, DOI )

  95. Yoshida S, Matsuoka Y, Toda K, Uehara S, Tanaka H, Yokoyama M, Saito K, Yoshimura R, Fujii Y. Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy. IJU case reports. 2021.07; 4 (4): 228-230. ( PubMed, DOI )

  96. Yoshida Soichiro, Matsuoka Yoh, Toda Kazuma, Uehara Sho, Tanaka Hajime, Yokoyama Minato, Saito Kazutaka, Yoshimura Ryoichi, Fujii Yasuhisa. 外部放射線療法後の非転移性去勢抵抗性前立腺癌に対する救済小線源療法による治療(Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy) IJU Case Reports. 2021.07; 4 (4): 228-230. ( ichushi )

  97. Yasuda Yosuke, Saito Kazutaka, Tanaka Hajime, Uehara Sho, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa. Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique INTERNATIONAL JOURNAL OF UROLOGY. 2021.03; 28 (3): 302-307. ( PubMed, DOI )

  98. Yamamoto S, Yoshida S, Ishii C, Takahara T, Arita Y, Fukushima H, Tanaka H, Yokoyama M, Matsuoka Y, Fujii Y. Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer. Journal of magnetic resonance imaging : JMRI. 2021.03; 54 (2): 401-408. ( PubMed, DOI )

  99. Sweet DE, Ward RD, Wang Y, Tanaka H, Campbell SC, Remer EM. Infiltrative Renal Malignancies: Imaging Features, Prognostic Implications, and Mimics. Radiographics : a review publication of the Radiological Society of North America, Inc. 2021.03; 41 (2): 487-508. ( PubMed, DOI )

  100. Yasuda Yosuke, Saito Kazutaka, Tanaka Hajime, Uehara Sho, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa. 連続患者356例におけるガスレス単孔式腹腔鏡下腎部分切除術の治療成績　無阻血および無縫合手技の実施可能性(Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique) International Journal of Urology. 2021.03; 28 (3): 302-307. ( ichushi )

  101. Tanaka H, Fujii Y. Editorial Comment. The Journal of urology. 2021.02; 205 (5): 101097JU000000000000154902-1320. ( PubMed, DOI )

  102. Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa. Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy: Potential of target margin and surrounding region sampling using magnetic resonance-ultrasound image fusion systems INTERNATIONAL JOURNAL OF UROLOGY. 2021.01; 28 (1): 127-129. ( PubMed, DOI )

  103. Soma T, Yokoyama M, Uchida Y, Kirimura S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report. International cancer conference journal. 2021.01; 10 (1): 20-23. ( PubMed, DOI )

  104. Yoshida Soichiro, Takahara Taro, Arita Yuki, Toda Kazuma, Yamada Ichiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa. Genuine- and induced-oligometastatic castration-resistant prostate cancer: clinical features and clinical outcomes after progressive site-directed therapy INTERNATIONAL UROLOGY AND NEPHROLOGY. 2021.01; 53 (6): 1119-1125. ( PubMed, DOI )

  105. Tanaka Hajime, Fujii Yasuhisa. Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence INTERNATIONAL JOURNAL OF UROLOGY. 2021.01; 28 (1): 16. ( PubMed, DOI )

  106. Fukushima Hiroshi, Yoshida Soichiro, Kijima Toshiki, Nakamura Yuki, Fukuda Shohei, Uehara Sho, Yasuda Yosuke, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Fujii Yasuhisa. Combination of Cisplatin and Irradiation Induces Immunogenic Cell Death and Potentiates Postirradiation Anti-PD-1 Treatment Efficacy in Urothelial Carcinoma INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021.01; 22 (2): ( PubMed, DOI )

  107. Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa. systematic biopsyにより標的生検からアップグレードした前立腺癌の三次元解析　磁気共鳴-超音波画像融合システムを用いた標的辺縁部および周辺領域のサンプリングの可能性(Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy: Potential of target margin and surrounding region sampling using magnetic resonance-ultrasound image fusion systems) International Journal of Urology. 2021.01; 28 (1): 127-129. ( ichushi )

  108. Soma Takahiko, Yokoyama Minato, Uchida Yusuke, Kirimura Susumu, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Fujii Yasuhisa. 膀胱増大に起因する扁平上皮癌とリンパ節転移に対して根治的膀胱切除術と腸間膜リンパ節郭清を行い長期生存した症例　1症例報告(Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report) International Cancer Conference Journal. 2021.01; 10 (1): 20-23. ( ichushi )

  109. Tanaka Hajime, Fujii Yasuhisa. 「膀胱癌に対するリンパ節郭清　現行の基準と最新のエビデンス」に対するエディトリアルコメント(Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence) International Journal of Urology. 2021.01; 28 (1): 16. ( ichushi )

  110. Yasuda Y, Saito K, Tanaka H, Uehara S, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Kihara K, Fujii Y. . Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique Int J Urol. 2020.12;

  111. Tanaka Hajime. Editorial Comment to Retroperitoneal tumors: Review of diagnosis and management(和訳中) International Journal of Urology. 2020.12; 27 (12): 1071. ( ichushi )

  112. Tanaka Hajime. Editorial Comment to Retroperitoneal tumors: Review of diagnosis and management INTERNATIONAL JOURNAL OF UROLOGY. 2020.12; 27 (12): 1071. ( PubMed, DOI )

  113. Palacios Diego Aguilar, Campbell Rebecca, Wang Yanbo, Tanaka Hajime, Ding Xiaobo, Ye Yun-Lin, Remer Erick M., Rizk Alain, Ward Ryan, Haywood Samuel, Campbell Steven C.. Infiltrative Renal Masses: Clinical Challenges UROLOGY. 2020.11; 145 3-8. ( PubMed, DOI )

  114. Fukushima Hiroshi, Kijima Toshiki, Fukuda Shohei, Moriyama Shingo, Uehara Sho, Yasuda Yosuke, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Saito Kazutaka, Matsubara Nobuaki, Numao Noboru, Sakai Yasuyuki, Yuasa Takeshi, Masuda Hitoshi, Yonese Junji, Kageyama Yukio, Fujii Yasuhisa. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary study CANCER MEDICINE. 2020.11; 9 (22): 8355-8363. ( PubMed, DOI )

  115. 福島 啓司, 木島 敏樹, 安田 庸輔, 森山 真吾, 上原 翔, 田中 一, 吉田 宗一郎, 横山 みなと, 松岡 陽, 松原 伸晃, 湯浅 健, 増田 均, 米瀬 淳二, 影山 幸雄, 藤井 靖久. 進行・転移性膀胱癌治療のup-to-date　進行尿路上皮癌に対するペムブロリズマブ治療における化学放射線療法の意義 日本癌治療学会学術集会抄録集. 2020.10; 58回 WS14-1. ( ichushi )

  116. 田中 一, 木島 敏樹, 福田 翔平, 福島 啓司, 安田 庸輔, 森山 真吾, 上原 翔, 吉田 宗一郎, 横山 みなと, 松岡 陽, 藤井 靖久. 局所限局性浸潤性膀胱癌の実践治療　筋層浸潤膀胱癌に対する4者併用膀胱温存療法 日本癌治療学会学術集会抄録集. 2020.10; 58回 WS13-1. ( ichushi )

  117. Tanaka Hajime. Editorial Comment to Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision INTERNATIONAL JOURNAL OF UROLOGY. 2020.09; 27 (9): 710. ( PubMed, DOI )

  118. Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Saito Kazutaka, Fujii Yasuhisa. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores: Spatial analysis using magnetic resonance-ultrasound fusion images(和訳中) International Journal of Urology. 2020.09; 27 (9): 760-766. ( ichushi )

  119. Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Saito Kazutaka, Fujii Yasuhisa. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores: Spatial analysis using magnetic resonance-ultrasound fusion images INTERNATIONAL JOURNAL OF UROLOGY. 2020.09; 27 (9): 760-766. ( PubMed, DOI )

  120. Fukushima Hiroshi, Fukuda Shohei, Moriyama Shingo, Uehara Sho, Yasuda Yosuke, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Fujii Yasuhisa. Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report ANTI-CANCER DRUGS. 2020.09; 31 (8): 866-871. ( PubMed, DOI )

  121. Tanaka Hajime. Editorial Comment to Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision(和訳中) International Journal of Urology. 2020.09; 27 (9): 710. ( ichushi )

  122. Kijima T, Fukushima H, Kusuhara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Sakai Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review Clin Genitourin Cancer. 2020.07;

  123. Nakamura Yuki, Yokoyama Minato, Yoshida Soichiro, Tanaka Hajime, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Minami Isao, Yoshimoto Takanobu, Naito Shotaro, Ogawa Yoshihiro, Yamada Tetsuya, Uchida Shinichi, Fujii Yasuhisa. クッシング症候群患者における副腎摘除後の術後腎機能障害と長期にわたる腎機能変化(Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome) International Journal of Urology. 2020.05; 27 (5): 395-400. ( ichushi )

  124. Tanaka Hajime, Fukushima Hiroshi, Kijima Toshiki, Nakamura Yuki, Yajima Shugo, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer INTERNATIONAL JOURNAL OF UROLOGY. 2020.03; 27 (3): 236-243. ( PubMed, DOI )

  125. Tanaka Hajime, Fujii Yasuhisa. Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort INTERNATIONAL JOURNAL OF UROLOGY. 2020.03; 27 (3): 257. ( PubMed, DOI )

  126. Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome. International journal of urology : official journal of the Japanese Urological Association. 2020.03; ( PubMed, DOI )

  127. Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome Int J Urol. 2020 Mar 11. doi: 10.1111/iju.14205. 2020.03;

  128. Tanaka Hajime, Fujii Yasuhisa. 「膀胱癌に対する根治的腹腔鏡下膀胱全摘術後の腫瘍学的成績と再発パターン　日本の多施設コホート」に対するDr.TanakaとDr.Fujiiによるエディトリアルコメント(Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort) International Journal of Urology. 2020.03; 27 (3): 257. ( ichushi )

  129. Tanaka Hajime, Fukushima Hiroshi, Kijima Toshiki, Nakamura Yuki, Yajima Shugo, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. 筋層浸潤性膀胱癌の高齢患者への選択的4者併用膀胱温存療法の実行可能性と成績(Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer) International Journal of Urology. 2020.03; 27 (3): 236-243. ( ichushi )

  130. Aguilar Palacios D, Caraballo ER, Tanaka H, Wang Y, Suk-Ouichai C, Ye Y, Lin L, Li J, Abouassaly R, Campbell SC. Compensatory Changes in Parenchymal Mass and Function after Radical Nephrectomy. The Journal of urology. 2020.02; 101097JU0000000000000797. ( PubMed, DOI )

  131. Ye Yunlin, Tanaka Hajime, Wang Yanbo, Campbell Rebecca A., Aguilar Palacios Diego, DeWitt-Foy Molly E., Mahmood Furman A., Eltemamy Mohamed, Remer Erick M., Li Jianbo, Campbell Steven C.. Split renal function in patients with renal masses: utility of parenchymal volume analysis vs nuclear renal scans BJU INTERNATIONAL. 2020.02; 125 (5): 686-694. ( PubMed, DOI )

  132. Tanaka H, Kijima T, Fujii Y. Bladder preservation therapy in muscle-invasive bladder cancer: Current evidence and future perspectives AME Medical Journal. 2020.02;

  133. Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer. European urology focus. 2020.01; 7 (2): 366-372. ( PubMed, DOI )

  134. Ye Y*, Tanaka H*, Wang Y, Campbell RA, Aguilar Palacios D, Dewitt-Foy ME, Mahmood FA, Eltemamy M, Remer EM, Li J, Campbell SC. Split Renal Function in Patients with Renal Masses: Utility of Parenchymal Volume Analysis versus Nuclear Renal Scans BJU International. 2020; 125: 686-694. *Equal contribution. 2020;

  135. Tanaka H. Editorial Comment to Retroperitoneal tumors: review of diagnosis and management Int J Urol. 2020; 27: 1071. 2020;

  136. Tanaka H. Editorial Comment to Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association -Summary of the Revision Int J Urol. 2020. doi: 10.1111/iju.14314. 2020;

  137. Tanaka H, Fukushima H, Kijima T, Nakamura Y, Yajima S, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer Int J Urol. 2020; 27: 236-243. *Equal contribution. 2020;

  138. Tanaka H, Fujii Y. Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence Int J Urol. 2020. doi: 10.1111/iju.14419. 2020;

  139. Tanaka H, Fujii Y. Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns following laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort Int J Urol. 2020. doi: 10.1111/iju.14194. 2020;

  140. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores Spatial analysis using magnetic resonance-ultrasound fusion images. Int J Urol. 2020; 27: 760-766. 2020;

  141. Fukushima H, Saito K, Yasuda Y, Tanaka H, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC) Clin Genitourin Cancer. 2020;

  142. Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer Eur Urol Focus. 2020;

  143. Fukushima H, Kijima T, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Matsubara N, Numao N, Sakai Y, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: a preliminary study Cancer Med. 2020; 9: 8355-8363. doi: 10.1002/cam4.3445. 2020;

  144. Fukushima H, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report Anticancer Drugs. 2020; 31: 866-871. doi: 10.1097/CAD.0000000000000982.. 2020;

  145. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Yokoyama M, Fujii Y. Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy Int J Urol. 2020 Oct 27. doi: 10.1111/iju.14410. 2020;

  146. ToshikiKijimaHajimeTanakaShoUeharaSoichiroYoshidaMinatoYokoyamaJunichiroIshiokaYohMatsuokaKazutakaSaitoKazunoriKiharaYasuhisaFujii. Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy 2019.12;

  147. Kijima T, Tanaka H, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy. Clinical genitourinary cancer. 2019.12; ( PubMed, DOI )

  148. Fukushima H, Saito K, Yasuda Y, Tanaka H, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC). Clinical genitourinary cancer. 2019.11; ( PubMed, DOI )

  149. Rebecca A Campbell, Molly E DeWitt-Foy, Hajime Tanaka, Yun-Lin Ye, Yanbo Wang, Jeffrey Reese, Venkatesh Krishnamurthi, Wen Dong, Steven C Campbell. Functional Recovery From Prolonged Warm Ischemia: Compelling Case Scenarios. Urology. 2019.10; 132 22-27. ( PubMed, DOI )

  150. Toshiki Kijima, Hajime Tanaka, Fumitaka Koga, Hitoshi Masuda, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients. BJU Int.. 2019.08; 124 (2): 242-250. ( PubMed, DOI )

  151. Masaki Kobayashi, Hajime Tanaka, Ukihide Tateishi, Noboru Numao, Junji Yonese, Masaya Ito, Fumitaka Koga, Hiroshi Fukushima, Sho Uehara, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinoma. Int. J. Urol.. 2019.08; 26 (8): 820-826. ( PubMed, DOI )

  152. Yanbo Wang, Hajime Tanaka, Yunlin Ye, Xiaobo Ding, Ryan D Ward, Rebecca A Campbell, Molly E DeWitt-Foy, Chalairat Suk-Ouichai, Erick M Remer, Steven C Campbell. The Complete Spectrum of Infiltrative Renal Masses: Clinical Characteristics and Prognostic Implications. Urology. 2019.08; 130 86-92. ( PubMed, DOI )

  153. Hajime Tanaka, Xiaobo Ding, Yunlin Ye, Yanbo Wang, Rebecca A Campbell, Molly E DeWitt-Foy, Chalairat Suk-Ouichai, Ryan D Ward, Erick M Remer, Jianbo Li, Steven C Campbell. Infiltrative Renal Masses: Clinical Significance and Fidelity of Documentation. Eur Urol Oncol. 2019.08; ( PubMed, DOI )

  154. Kobayashi Masaki, Tanaka Hajime, Tateishi Ukihide, Numao Noboru, Yonese Junji, Ito Masaya, Koga Fumitaka, Fukushima Hiroshi, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 転移性尿路上皮癌患者の化学療法感受性と生存率にPET/CTでのフルオロデオキシグルコース取り込みが及ぼす影響(Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinoma) International Journal of Urology. 2019.08; 26 (8): 820-826. ( ichushi )

  155. Chalairat Suk-Ouichai, Hajime Tanaka, Yanbo Wang, Jitao Wu, Yunlin Ye, Sevag Demirjian, Jianbo Li, Steven C Campbell. Renal Cancer Surgery in Patients without Preexisting Chronic Kidney Disease-Is There a Survival Benefit for Partial Nephrectomy? J. Urol.. 2019.06; 201 (6): 1088-1096. ( PubMed, DOI )

  156. Hiroshi Watanabe, Hajime Tanaka, Yasuhisa Fujii, Makoto Kodama, Takumi Akashi, Tomoyuki Fujioka, Kazunori Kubota, Yukihisa Saida, Ukihide Tateishi. A case of immunoglobulin G4-related inflammatory pseudotumor mimicking renal cell carcinoma. Abdom Radiol (NY). 2019.04; 44 (4): 1230-1236. ( PubMed, DOI )

  157. Hajime Tanaka, Yanbo Wang, Chalairat Suk-Ouichai, Diego Aguilar Palacios, Elvis R Caraballo, Yunlin Ye, Erick M Remer, Jianbo Li, Robert Abouassaly, Steven C Campbell. Can We Predict Functional Outcomes after Partial Nephrectomy? J. Urol.. 2019.04; 201 (4): 693-701. ( PubMed, DOI )

  158. Elvis R Caraballo, Diego Aguilar Palacios, Chalairat Suk-Ouichai, Jitao Wu, Wen Dong, Hajime Tanaka, Yanbo Wang, Brian R Lane, Steven C Campbell. Open partial nephrectomy when a non-flank approach is required: indications and outcomes. World J Urol. 2019.03; 37 (3): 515-522. ( PubMed, DOI )

  159. Jitao Wu, Chalairat Suk-Ouichai, Wen Dong, Zhiling Zhang, Hajime Tanaka, Yanbo Wang, Elvis Caraballo, Erick M Remer, Jianbo Li, Sudhir Isharwal, Robert Abouassaly, Steven C Campbell. Vascularized Parenchymal Mass Preserved with Partial Nephrectomy: Functional Impact and Predictive Factors. Eur Urol Oncol. 2019.02; 2 (1): 97-103. ( PubMed, DOI )

  160. Naoko Kawamura, Minato Yokoyama, Hajime Tanaka, Takayuki Nakayama, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy. Int. J. Urol.. 2019.01; 26 (1): 113-118. ( PubMed, DOI )

  161. Kawamura Naoko, Yokoyama Minato, Tanaka Hajime, Nakayama Takayuki, Yasuda Yosuke, Kijima Toshiki, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 無阻血腎部分切除術後の急性腎障害と中期腎機能(Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy) International Journal of Urology. 2019.01; 26 (1): 113-118. ( ichushi )

  162. Soma Takahiko, Ishioka Junichiro, Tanaka Hajime, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. 造影CTとT2強調MRIによる脂肪に乏しい血管筋脂肪腫の診断を目的とした畳み込みニューラルネットワークアルゴリズムを用いたコンピュータ補助診断の可能性(Potential for computer-aided diagnosis using a convolutional neural network algorithm to diagnose fat-poor angiomyolipoma in enhanced computed tomography and T2-weighted magnetic resonance imaging) International Journal of Urology. 2018.11; 25 (11): 978-979. ( ichushi )

  163. Ryan D Ward, Hajime Tanaka, Steven C Campbell, Erick M Remer. 2017 AUA Renal Mass and Localized Renal Cancer Guidelines: Imaging Implications. Radiographics. 2018.11; 38 (7): 2021-2033. ( PubMed, DOI )

  164. Yasuda Yosuke, Saito Kazutaka, Soma Takahiko, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa. Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy: Perioperative outcomes INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 230.

  165. Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 234.

  166. Takahiko Soma, Junichiro Ishioka, Hajime Tanaka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Potential for computer-aided diagnosis using a convolutional neural network algorithm to diagnose fat-poor angiomyolipoma in enhanced computed tomography and T2-weighted magnetic resonance imaging. Int. J. Urol.. 2018.08; ( PubMed, DOI )

  167. Alice Crane, Chalairat Suk-Ouichai, Jack A Campbell, Elvis R Caraballo, Diego Aguilar Palacios, Hajime Tanaka, Steven C Campbell. Imprudent Utilization of Partial Nephrectomy. Urology. 2018.07; 117 22-26. ( PubMed, DOI )

  168. Hajime Tanaka, Soichiro Yoshida, Fumitaka Koga, Kazuma Toda, Ryoichi Yoshimura, Yutaka Nakajima, Emiko Sugawara, Takumi Akashi, Yuma Waseda, Masaharu Inoue, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys.. 2018.06; ( PubMed, DOI )

  169. Chalairat Suk-Ouichai, Jitao Wu, Wen Dong, Hajime Tanaka, Yanbo Wang, J J H Zhang, Elvis Caraballo, Erick Remer, Jianbo Li, Sudhir Isharwal, Steven C Campbell. Tumor Contact Surface Area As a Predictor of Functional Outcomes After Standard Partial Nephrectomy: Utility and Limitations. Urology. 2018.06; 116 106-113. ( PubMed, DOI )

  170. Moriyama Shingo, Yoshida Soichiro, Tanaka Hajime, Tanaka Hiroshi, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. T2強調MRIにおける小径腎腫瘍の信号強度比曲線解析　脂肪成分の少ない腎血管筋脂肪腫と腎細胞癌との鑑別(Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma) International Journal of Urology. 2018.06; 25 (6): 554-560. ( ichushi )

  171. Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. pT1膀胱癌の進行に関する拡散強調MRI上のinchworm sign欠如の予測的意義(Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer) 日本泌尿器科学会総会. 2018.04; 106回 IS-75. ( ichushi )

  172. Yasuda Yosuke, Saito Kazutaka, Soma Takahiko, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa. ガスレス単孔式腹腔鏡下clampless無縫合腎部分切除術　周術期転帰(Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy: Perioperative outcomes) 日本泌尿器科学会総会. 2018.04; 106回 IS-68. ( ichushi )

  173. Shingo Moriyama, Soichiro Yoshida, Hajime Tanaka, Hiroshi Tanaka, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma. Int. J. Urol.. 2018.03; ( PubMed, DOI )

  174. Sho Uehara, Soichiro Yoshida, Hiroshi Tanaka, Yosuke Yasuda, Hajime Tanaka, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Prediction of Intraoperative Urinary Collecting System Entry in Patients with Peripheral Renal Tumors Undergoing Partial Nephrectomy: Usefulness of Tumor-Centered Multiplanar Reconstruction. Urol. Int.. 2018.01; 100 (1): 85-91. ( PubMed, DOI )

  175. Yoh Matsuoka, Junichiro Ishioka, Hiroshi Tanaka, Tomo Kimura, Soichiro Yoshida, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Impact of the Prostate Imaging Reporting and Data System, Version 2, on MRI Diagnosis for Extracapsular Extension of Prostate Cancer. AJR Am J Roentgenol. 2017.08; 209 (2): W76-W84. ( PubMed, DOI )

  176. Toshinori Nishizawa, Soichiro Yoshida, Fumitaka Koga, Hiroshi Tanaka, Mihiro Kaga, Kotaro Watanabe, Hiroshi Fukushima, Yasukazu Nakanishi, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Standardization of the apparent diffusion coefficient value of bladder cancer across different centers: Applicability in predicting aggressive pathologic phenotypes. Clin Imaging. 2017.07; 44 121-126. ( PubMed, DOI )

  177. Hajime Tanaka, Yasuhisa Fujii, Hiroshi Tanaka, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Sho Uehara, Noboru Numao, Takeshi Yuasa, Shinya Yamamoto, Hitoshi Masuda, Junji Yonese, Kazunori Kihara. Stepwise algorithm using computed tomography and magnetic resonance imaging for diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation. Int. J. Urol.. 2017.07; 24 (7): 511-517. ( PubMed, DOI )

  178. Tanaka Hajime, Fujii Yasuhisa, Tanaka Hiroshi, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Uehara Sho, Numao Noboru, Yuasa Takeshi, Yamamoto Shinya, Masuda Hitoshi, Yonese Junji, Kihara Kazunori. 小径腎腫瘍中の脂肪成分の少ない腎血管筋脂肪腫診断のためのCTおよびMRIを用いたステップワイズアルゴリズム　開発および外的妥当性(Stepwise algorithm using computed tomography and magnetic resonance imaging for diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation) International Journal of Urology. 2017.07; 24 (7): 511-517. ( ichushi )

  179. Hajime Tanaka, Yasuhisa Fujii, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara. Absence of renal artery pseudoaneurysm on computed tomography after minimally-invasive partial nephrectomy using clampless and sutureless techniques. Int. J. Urol.. 2017.06; 24 (6): 472-473. ( PubMed, DOI )

  180. Tanaka Hajime, Fujii Yasuhisa, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori. 無阻血・無縫合法による低侵襲性腎部分切除術後のCTにおける仮性腎動脈瘤の非描出(Absence of renal artery pseudoaneurysm on computed tomography after minimally-invasive partial nephrectomy using clampless and sutureless techniques) International Journal of Urology. 2017.06; 24 (6): 472-473. ( ichushi )

  181. Tanaka Hajime, Yoshida Soichiro, Inoue Masaharu, Ito Masaya, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 免疫組織化学に基づいた分子的サブタイプ判定による筋層浸潤性膀胱癌における化学放射線療法に対する感受性の予測(Immunohistochemistry-based molecular subtypes predict therapeutic sensitivity of chemoradiotherapy in muscle-invasive bladder cancer) 日本泌尿器科学会総会. 2017.04; 105回 AOP11-07. ( ichushi )

  182. Yuki Nakamura, Soichiro Yoshida, Hiroshi Tanaka, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection. Urol. Int.. 2017.03; 98 (3): 298-303. ( PubMed, DOI )

  183. Hajime Tanaka, Soichiro Yoshida, Yoshinobu Komai, Yasuyuki Sakai, Shinji Urakami, Takeshi Yuasa, Shinya Yamamoto, Hitoshi Masuda, Mitsuru Koizumi, Atsushi Kohno, Iwao Fukui, Junji Yonese, Yasuhisa Fujii, Kazunori Kihara. Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management. Urol. Int.. 2016.01; 96 (1): 65-72. ( PubMed, DOI )

  184. Shinji Urakami, Takeshi Yuasa, Shinya Yamamoto, Mizuaki Sakura, Hajime Tanaka, Tatsuro Hayashi, Sho Uehara, Yasushi Inoue, Yasuhisa Fujii, Hitoshi Masuda, Iwao Fukui, Junji Yonese. Clinical response to induction chemotherapy predicts improved survival outcome in urothelial carcinoma with clinical lymph nodal metastasis treated by consolidative surgery. Int. J. Clin. Oncol.. 2015.12; 20 (6): 1171-1178. ( PubMed, DOI )

  185. Takeshi Yuasa, Naoko Inoshita, Hajime Tanaka, Shinji Urakami, Shinya Yamamoto, Yasuhisa Fujii, Hitoshi Masuda, Iwao Fukui, Yuichi Ishikawa, Junji Yonese. Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era. Int. J. Clin. Oncol.. 2015.12; 20 (6): 1198-1202. ( PubMed, DOI )

  186. Hajime Tanaka, Takeshi Yuasa, Yasuhisa Fujii, Mizuaki Sakura, Shinji Urakami, Shinya Yamamoto, Hitoshi Masuda, Iwao Fukui, Junji Yonese. First-line combination chemotherapy with cisplatin, etoposide and ifosfamide for the treatment of disseminated germ cell cancer: re-evaluation in the granulocyte colony-stimulating factor era. Chemotherapy. 2013; 59 (6): 441-446. ( PubMed, DOI )

  187. Yuma Waseda, Hajime Tanaka, Kazuaki Nakagomi, Shuichi Goto, Akio Ido. A case of hereditary persistence of α-fetoprotein: diagnostic usefulness of the subfraction profile. Jpn. J. Clin. Oncol.. 2012.08; 42 (8): 767-769. ( PubMed, DOI )

  188. Yoshida Soichiro, Koga Fumitaka, Kobayashi Shuichiro, Ishii Chikako, Tanaka Hiroshi, Tanaka Hajime, Komai Yoshinobu, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys. 2012.05; 83 (1): e21-e27. ( PubMed, DOI )

  189. Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa, Ishii Chikako, Tanaka Hiroshi, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Kawakami Satoru, Kihara Kazunori. Diffusion-weighted magnetic resonance imaging in the differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma. Int J Urol. 2011.10; 18 (10): 727-730. ( PubMed, DOI )

< PREV - NEXT >

  • 1
To the head of this page.▲